Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 303OTHER 135OTHER_GOV 4NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 19Mesothelioma, Malignant 13Retinoblastoma 8Unspecified Childhood Solid Tumor, Protocol Specific 6Malignant Solid Neoplasm 4Sarcoma 3Neuroblastoma 3Wilms Tumor 2Solitary Fibrous Tumor, Pleural 2Solid Tumor 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteosarcoma 2Optic Nerve Glioma 2Neoplasms 2Mesothelioma 2Melanoma 2Medulloblastoma 2Lymphoma 2Leukemia 2Hematopoietic and Lymphatic System Neoplasm 2Gestational Trophoblastic Disease 2Central Nervous System Neoplasms 2Astrocytoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Thrombocytopenia 1Testicular Neoplasms 1Solid Tumor Spine Metastases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Solid Tumor × Other solid neoplasm × Clear all
NCT06524024 2025-02-10

DC-CTL

Zhengzhou Revo-Gene Technology Co., LTD

Phase NA Not yet recruiting
20 enrolled
Other solid neoplasm

Solid Tumor

NCT01798654 2016-02-19

EUS-FNA for Patients With Antithrombotic Agents

Hokkaido Pancreatobiliary Endoscopic Intervention Study Group

Completed
84 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡